Jul 25, 2014 at 21:22 | Source: CNBC-TV18
The pressure is building up on the Indian drug regulator to clampdown on the fake drugs that are inundating the Indian market. A desperate CDSCO has decided to restart an old scheme -- reward to any whistleblower who is instrumental in the seizure of counterfeit drugs and cosmetics.
Jul 25, 2014 at 20:15 | Source: CNBC-TV18
An expert panel consisting Rashesh Shah, Chairman and CEO of the Edelweiss Financial Services Group, Kewal Handa, Former Managing Director of Pfizer India and Piruz Khambatta, Chairman Private limited discuss the agenda for the government beyond Budget 2014s hits and misses on Change Indias second episode.
Jul 24, 2014 at 16:51 | Source: PTI
Net sales of Pfizer, rose to Rs 239.85 crore during the first quarter, as compared to Rs 237.53 crore in the same period of previous fiscal
Jul 24, 2014 at 08:14 | Source: CNBC-TV18
Ranbaxy Labs | Wipro | TVS Motor | Cairn India | Cipla | Bank of India | Container Corporation | Geometric | Gujarat Alkalies | Alstom T&D India | McLeod Russel | L&T Finance Holdings | Panacea Biotec | Prestige Estates | Liberty Shoes | Patel Engineering | JSW Energy and ACC are stocks, which are in the news today.
Jul 23, 2014 at 10:42 | Source: Moneycontrol.com
With DPCO coverage extending to almost about 40 percent of the industry, the profitability in the domestic business of pharma companies is likely to come under pressure, says an ICRA report.
Jul 16, 2014 at 18:37 | Source: PTI
The FIPB, however, rejected an investment proposal of Multi-Commodity Exchange of India (MCX) for a post-facto approval of the foreign investment made by Alexandra Mauritius Ltd prior to the period when FDI in commodity exchanges was brought under approval route.
Jul 14, 2014 at 12:12 | Source: CNBC-TV18
According to Kewal Handa, the pricing regulator (NPPA) has fixed prices of medicines that are not included in the national list of essential medicines (NLEM) and may also add more drugs, especially the cancer drugs going ahead.
Jun 30, 2014 at 11:56 | Source: Reuters
Corporate buyers did not shy away from going hostile if their targets proved unwilling to sell, while more US companies rushed to buy overseas peers to lower tax rates and access cash held offshore in a practice known as inversion.
Jun 23, 2014 at 20:33 | Source: CNBC
"I've felt for some time that the ultimate bubble, when we look back a few years from now, is going to be sovereign debt, both US and other, because it's way below any sort of reversion to the mean of interest rates," the distressed debt investor told CNBC.
Jun 23, 2014 at 09:49 | Source: Moneycontrol.com
The company, had earlier, deferred the delisting plan due to the big deal which was expected in the parent company Astrazeneca. Pfizer was looking to buy out the whole company because of which the whole delisting plan got deferred.